Fig. 2: Analysis of CD16 and CD62L Neutrophil Subopulations and Marker Expression in Lymph Nodes. | British Journal of Cancer

Fig. 2: Analysis of CD16 and CD62L Neutrophil Subopulations and Marker Expression in Lymph Nodes.

From: Phenotypical differences of neutrophils patrolling tumour-draining lymph nodes in head and neck cancer

Fig. 2

Comparison of CD16highCD62Lhigh/CD16highCD62Ldim populations between patients with N0 and N+ stage in nTDLNs (a) and TDLNs (b). Comparison of CD16highCD62Lhigh/CD16highCD62Ldim populations between patients with T1-T2 stage and T3-T4 stage in nTDLNs (c) and TDLNs (d). e Expression of CD184 across analyzed compartments. The number of samples was as follows: hLNs (n = 12), n-TDLNs (n = 23), TDLNs (n = 102) and tumour samples (n = 16). f Expression of CD11b across analyzed compartments. The number of samples was as follows: hLNs (n = 12), n-TDLNs (n = 23), TDLNs (n = 102) and tumour samples (n = 16)

Back to article page